Sign In
Buy DTIL
$6.04
-0.280 (-4.43%)
At Close: Jun 03, 2026
AstraZeneca ‘probably couldn’t run Gilead any better:’ analyst -
08:53am, Tuesday, 09'th Jun 2020
AstraZeneca probably couldn’t run Gilead any better, says analyst
Arcus Biosciences Announces New Employment Inducement Grants
12:00am, Tuesday, 09'th Jun 2020
Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced t
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma
11:00am, Monday, 08'th Jun 2020
Precision BioSciences, Inc. (DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform, today announced that the first pa
Norway’s domestic liquor sales up 44% in May
09:29am, Monday, 08'th Jun 2020
Norway closed its borders in mid-March to most foreigners and imposed quarantines on anyone returning home from abroad, while also shutting its restaurants, thus leaving Vinmonopolet as the only sourc
Norway's domestic liquor sales up 44% in May
05:18am, Monday, 08'th Jun 2020
OSLO, June 8 (Reuters) - Norway's government-run wine and liquor monopoly increased its sales by 44% in May from the same month last year as coronavirus...
Bulls And Bears Of The Week: Gilead, Shopify, Tesla And More
12:00am, Saturday, 06'th Jun 2020
Benzinga has examined the prospects for many investor favorite stocks over the past week.
This week's bullish calls included semiconductor and casino stocks.
Cruise and...
Mereo raises $70m as TIGIT cancer drug progresses in clinic -
04:35pm, Thursday, 04'th Jun 2020
Mereo BioPharma has raised $70m to develop its next-generation anti-TIGIT cancer checkpoint inhibitor drug.
Yearly Gainers: $RCUS $FVRR $VIR
02:04pm, Monday, 01'st Jun 2020
Jun 01, 2020 (The Market Signal via Comtex) --
The Market Signal was created as a platform to help investors find the best free Stock Reports on stocks they...
Xconomy: Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact
08:36pm, Wednesday, 27'th May 2020
With the year’s biggest oncology conference days away, Gilead Sciences is signaling now what its cancer immunotherapy pipeline could look like in the
Gilead & Arcus Join Forces For 10-Year Cancer Deal, Arcus Down 15% In Pre-Market
12:59pm, Wednesday, 27'th May 2020
Gilead Sciences (GILD) and Arcus Biosciences (RCUS), an oncology-focused biopharma, have announced a 10-year partnership to co-develop and
Precision BioSciences to Present at Upcoming Investor Conferences
08:01pm, Tuesday, 26'th May 2020
DURHAM, N.C., May 26, 2020 -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary.
Heart attack symptoms: The sign on your eyelids that could signal you are at risk
07:09am, Tuesday, 26'th May 2020
HEART attacks are a potentially deadly complication but your risk of having one can be signalled long before the event itself. One way to tell you are at risk can be spotted on your eyelids.
Arcus Expands Cash-to-Digital Solution Network to include 65,000 Points of Sale
12:00am, Wednesday, 20'th May 2020
Arcus, leading fintech provider now offers largest Cash-to-Digital network in Mexico with 65,000 participating locations.
These Analysts Just Made A Decent Downgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) EPS Forecasts
10:34am, Monday, 18'th May 2020
The analysts covering Precision BioSciences, Inc. (NASDAQ:DTIL) delivered a dose of negativity to shareholders today...
